IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v5y2014i1d10.1038_ncomms4897.html
   My bibliography  Save this article

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

Author

Listed:
  • Nadine J. Ortner

    (Center for Molecular Biosciences, University of Innsbruck)

  • Gabriella Bock

    (Center for Molecular Biosciences, University of Innsbruck)

  • David H.F. Vandael

    (Laboratory of Cellular and Molecular Neuroscience, Nanostructured Interfaces and Surfaces Center)

  • Robert Mauersberger

    (Center for Molecular Biosciences, University of Innsbruck)

  • Henning J. Draheim

    (Boehringer Ingelheim Pharma GmbH & Co KG, CNS Research)

  • Ronald Gust

    (Center for Molecular Biosciences, University of Innsbruck)

  • Emilio Carbone

    (Laboratory of Cellular and Molecular Neuroscience, Nanostructured Interfaces and Surfaces Center)

  • Petronel Tuluc

    (Center for Molecular Biosciences, University of Innsbruck)

  • Jörg Striessnig

    (Center for Molecular Biosciences, University of Innsbruck)

Abstract

Cav1.2 and Cav1.3 are the main L-type Ca2+ channel subtypes in the brain. Cav1.3 channels have recently been implicated in the pathogenesis of Parkinson’s disease. Therefore, Cav1.3-selective blockers are developed as promising neuroprotective drugs. We studied the pharmacological properties of a pyrimidine-2,4,6-trione derivative (1-(3-chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione, Cp8) recently reported as the first highly selective Cav1.3 blocker. Here we show, in contrast to this previous study, that Cp8 reproducibly increases inward Ca2+ currents of Cav1.3 and Cav1.2 channels expressed in tsA-201 cells by slowing activation, inactivation and enhancement of tail currents. Similar effects are also observed for native Cav1.3 and Cav1.2 channels in mouse chromaffin cells, while non-L-type currents are unaffected. Evidence for a weak and non-selective inhibition of Cav1.3 and Cav1.2 currents is only observed in a minority of cells using Ba2+ as charge carrier. Therefore, our data identify pyrimidine-2,4,6-triones as Ca2+ channel activators.

Suggested Citation

  • Nadine J. Ortner & Gabriella Bock & David H.F. Vandael & Robert Mauersberger & Henning J. Draheim & Ronald Gust & Emilio Carbone & Petronel Tuluc & Jörg Striessnig, 2014. "Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators," Nature Communications, Nature, vol. 5(1), pages 1-10, September.
  • Handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4897
    DOI: 10.1038/ncomms4897
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms4897
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms4897?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Pietro Mesirca & Jean Chemin & Christian Barrère & Eleonora Torre & Laura Gallot & Arnaud Monteil & Isabelle Bidaud & Sylvie Diochot & Michel Lazdunski & Tuck Wah Soong & Stéphanie Barrère-Lemaire & M, 2024. "Selective blockade of Cav1.2 (α1C) versus Cav1.3 (α1D) L-type calcium channels by the black mamba toxin calciseptine," Nature Communications, Nature, vol. 15(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4897. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.